Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Liver immunity

Unveiling the antitumor function of ID3 in liver macrophages

Nature Immunology volume 25, pages 394–395 (2024)Cite this article

Subjects

A landmark study reveals how Kupffer cells, resident macrophages of the liver, can promote antitumor immunity. Central to this function is ID3, a Kupffer cell lineage-determining factor. The findings provide new insights into cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: KCs, liver-resident macrophages, are endowed with natural antitumor capabilities promoted by ID3.

References

  1. Deng, Z. et al. Nature https://doi.org/10.1038/s41586-023-06950-4 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cassetta, L. & Pollard, J. W. Nat. Rev. Cancer 23, 238–257 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. Pittet, M. J., Michielin, O. & Migliorini, D. Nat. Rev. Clin. Oncol. 19, 402–421 (2022).

    Article  PubMed  Google Scholar 

  4. Hanahan, D. Cancer Discov. 12, 31–46 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Binnewies, M. et al. Nat. Med. 24, 541–550 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Franklin, R. A. et al. Science 344, 921–925 (2014).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhu, Y. et al. Immunity 47, 323–338.e6 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Casanova-Acebes, M. et al. Nature 595, 578–584 (2021).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  9. Nalio Ramos, R. et al. Cell 185, 1189–1207.e25 (2022).

    Article  CAS  PubMed  Google Scholar 

  10. Paget, S. Lancet 133, 571–573 (1889).

    Article  Google Scholar 

  11. Siwicki, M. et al. Sci. Immunol. 6, eabi7083 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland

    Anne-Gaëlle Goubet & Mikaël J. Pittet

  2. AGORA Cancer Research Center, Swiss Cancer Center Leman, Lausanne, Switzerland

    Anne-Gaëlle Goubet & Mikaël J. Pittet

  3. Ludwig Institute for Cancer Research, Lausanne, Switzerland

    Mikaël J. Pittet

  4. Department of Oncology, Geneva University Hospitals (HUG), Geneva, Switzerland

    Mikaël J. Pittet

Authors
  1. Anne-Gaëlle Goubet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikaël J. Pittet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mikaël J. Pittet.

Ethics declarations

Competing interests

M.J.P. has served as a consultant for AstraZeneca, Elstar Therapeutics, ImmuneOncia, KSQ Therapeutics, LegoChem Bio, Merck, Siamab Therapeutics, Third Rock Ventures, Tidal and Unikum.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goubet, AG., Pittet, M.J. Unveiling the antitumor function of ID3 in liver macrophages. Nat Immunol 25, 394–395 (2024). https://doi.org/10.1038/s41590-024-01761-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-024-01761-9

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing